NCT04689347
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04689347
Title 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
Fondazione IRCCS Istituto Nazionale dei Tumori RECRUITING Milan Milan 20133 Italy Details
Istituto Oncologico Veneto IRCCS RECRUITING Padua PD 35128 Italy Details
Ospedale Santa Chiara RECRUITING Pisa PI 56126 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field